EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

An Engineered N-Glycosylated Dengue Envelope Protein Domain III Facilitates Epitope-Directed Selection of Potently Neutralizing and Minimally Enhancing Antibodies

Napon Nilchan iD, Romchat Kraivong, Prasit Luangaram, Anunyaporn Phungsom, Mongkhonphan Tantiwatcharakunthon, Somchoke Traewachiwiphak iD, Tanapan Prommool, Nuntaya Punyadee, Panisadee Avirutnan iD, Thaneeya Duangchinda, Prida Malasit, Chunya Puttikhunt

ACS Infectious Diseases · 2024

DOI: 10.1021/acsinfecdis.4c00058 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Infectious Diseases, 2024. Verfasst von Napon Nilchan und 11 weiteren Autor:innen. Beteiligte Einrichtung: Molecular Biology of Dengue and Flaviviruses Research Team, Medical Molecular Biotechnology Research Group National Science and Technology Developmen…. Hauptthemen laut MEDLINE: Antibodies, Neutralizing, Dengue Virus, Viral Envelope Proteins, Epitopes. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Center for Genetic Engineering and Biotechnology, National Research Council of Thailand.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antibodies, NeutralizingDengue VirusViral Envelope ProteinsEpitopesAntibodies, ViralSingle-Chain AntibodiesGlycosylationHumansAnimalsMiceDengueProtein EngineeringAntibody-Dependent EnhancementProtein Domains

Stichwörter der Autor:innen

denguedomain IIIenvelopeepitopeglycanshield

Substanzen

Antibodies, NeutralizingViral Envelope ProteinsEpitopesAntibodies, ViralSingle-Chain Antibodies

Autor:innen und Institutionen

  • Molecular Biology of Dengue and Flaviviruses Research Team, Medical Molecular Biotechnology Research Group National Science and Technology Development Agency (NSTDA), Pathum Thani 12120, Thailand.
  • Siriraj Center of Research Excellence in Dengue and Emerging Pathogens Mahidol University, Bangkok 10700, Thailand.
  • Division of Dengue Hemorrhagic Fever Research, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok 10700, Thailand.
  • Medical Biotechnology Research Unit, National Center for Genetic Engineering and Biotechnology (BIOTEC), National Science and Technology Development Agency (NSTDA), Pathum Thani 12120, Thailand.

ORCID-Profile: Napon Nilchan, Somchoke Traewachiwiphak, Panisadee Avirutnan

Förderung

  • National Center for Genetic Engineering and Biotechnology
  • National Research Council of Thailand

Zitieren

APA

Nilchan, N., Kraivong, R., Luangaram, P., Phungsom, A., Tantiwatcharakunthon, M., Traewachiwiphak, S., Prommool, T., Punyadee, N., Avirutnan, P., Duangchinda, T., Malasit, P., & Puttikhunt, C. (2024). An Engineered N-Glycosylated Dengue Envelope Protein Domain III Facilitates Epitope-Directed Selection of Potently Neutralizing and Minimally Enhancing Antibodies. ACS Infectious Diseases. https://doi.org/10.1021/acsinfecdis.4c00058

Vancouver

Nilchan N, Kraivong R, Luangaram P, Phungsom A, Tantiwatcharakunthon M, Traewachiwiphak S, et al. An Engineered N-Glycosylated Dengue Envelope Protein Domain III Facilitates Epitope-Directed Selection of Potently Neutralizing and Minimally Enhancing Antibodies. ACS Infectious Diseases. 2024. doi:10.1021/acsinfecdis.4c00058

BibTeX
@article{Nilchan2024,
  author = {Nilchan, Napon and Kraivong, Romchat and Luangaram, Prasit and Phungsom, Anunyaporn and Tantiwatcharakunthon, Mongkhonphan and Traewachiwiphak, Somchoke and Prommool, Tanapan and Punyadee, Nuntaya and Avirutnan, Panisadee and Duangchinda, Thaneeya and Malasit, Prida and Puttikhunt, Chunya},
  title = {An Engineered N-Glycosylated Dengue Envelope Protein Domain III Facilitates Epitope-Directed Selection of Potently Neutralizing and Minimally Enhancing Antibodies},
  journal = {ACS Infectious Diseases},
  year = {2024},
  doi = {10.1021/acsinfecdis.4c00058}
}
Kostenlos starten →